Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma

Published:2020-08-27 Issue:10 Volume:111 Page:3665-3678
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Song Huijuan¹,Sun Ning¹,Lin Lin¹,Wei Shan¹,Zeng Kai¹,Liu Wei¹,Wang Chunyu¹,Zhong Xinping²,Wang Manlin¹,Wang Shengli¹,Zhou Baosheng¹,Lv Chi³,Liu Wensu¹,Zhao Yue¹⁴^ORCID

Affiliation:

1. Department of Cell Biology Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology Ministry of Education School of Life Sciences China Medical University Shenyang City China

2. Department of General Surgery The First Affiliated Hospital of China Medical University Shenyang City China

3. Department of General Surgery Shengjing Hospital of China Medical University Shenyang City China

4. Department of Endocrinology and Metabolism Institute of Endocrinology The First Affiliated Hospital of China Medical University Shenyang City China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14595

Reference38 articles.

1. Hepatocellular carcinoma

2. HBV infection and HCC: the ‘dangerous liaisons’